Acumen Pharmaceuticals (ABOS) Treasury Shares (2020 - 2026)
Acumen Pharmaceuticals (ABOS) posted Treasury Shares of $2.8 million for Q1 2026, up 44.72% sequentially from $1.9 million in Q4 2025, and up 49.49% YoY from $1.8 million in Q1 2025.
Acumen Pharmaceuticals (ABOS) Treasury Shares (2020 - 2026) Analysis & Trends
Acumen Pharmaceuticals has reported Treasury Shares for 6 years, with the latest figure at $2.8 million in Q1 2026.
- Quarterly Treasury Shares rose 49.49% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (up 49.49% YoY) and the FY2025 annual result came in at $1.9 million, up 40.86% from the prior year.
- Treasury Shares rose to $2.8 million in Q1 2026 per ABOS's latest filing, from $1.9 million in the prior quarter.
- Over five years, Treasury Shares peaked at $2.8 million in Q1 2026 and troughed at $328500.0 in Q1 2023.
- A 4-year average of $1.3 million and a median of $1.4 million in 2024 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares jumped 333.38% in 2024, then advanced 29.75% in 2025.
- Over 4 years, Treasury Shares stood at $328500.0 in 2023, then surged by 312.34% to $1.4 million in 2024, then surged by 40.86% to $1.9 million in 2025, then jumped by 44.72% to $2.8 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $2.8 million, $1.9 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Acumen Pharmaceuticals | 226.87 Mn | 226.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.06 Mn |
| Jun 30, 2026 | 3.06 Mn |
| Mar 31, 2026 | 2.76 Mn |
| Mar 31, 2026 | 2.76 Mn |
| Dec 31, 2025 | 1.91 Mn |
| Dec 31, 2025 | 1.91 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 1.92 Mn |
| Jun 30, 2025 | 1.92 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Mar 31, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.42 Mn |